Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease.
Carbone
A
A
Division of Pathology, Istituto Nazionale Tumori, IRCCS, Aviano, Italy.
Gloghini
A
A
Gaidano
G
G
D001402:B-Lymphocytes / Q000737:chemistry*; D015415:Biomarkers / Q000032:analysis; D019013:CD40 Antigens / Q000032:analysis; D023201:CD40 Ligand; D004268:DNA-Binding Proteins / Q000032:analysis*; D006679:HIV Seropositivity / Q000473:pathology; D006689:Hodgkin Disease / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D008562:Membrane Glycoproteins / Q000032:analysis*; D011509:Proteoglycans / Q000032:analysis*; D011518:Proto-Oncogene Proteins / Q000032:analysis*; D051560:Proto-Oncogene Proteins c-bcl-6; D053668:Syndecan-1; D053667:Syndecans; D014157:Transcription Factors / Q000032:analysis*
D015415:Biomarkers; D019013:CD40 Antigens; D004268:DNA-Binding Proteins; D008562:Membrane Glycoproteins; D011509:Proteoglycans; D011518:Proto-Oncogene Proteins; D051560:Proto-Oncogene Proteins c-bcl-6; C508241:SDC1 protein, human; D053668:Syndecan-1; D053667:Syndecans; D014157:Transcription Factors; D023201:CD40 Ligand